Perspectives from Christian Angermayer, investor and founder in psychedelics

Business Trip

English - October 27, 2022 19:00 - 42 minutes - 29.3 MB
Entrepreneurship Business Health & Fitness Mental Health psychedelics psychedelic psychedelic startups mental health wellness human flourishing Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Soltara: an ethical and profitable ayahuasca retreat

Next Episode: Transcranial magnetic stimulation (TMS) paired with ketamine: inside a clinic offering a frontier treatment

In this week's episode, we chat with Christian Angermayer. Christian co-founded atai Life Sciences and was an early investor in Compass Pathways -- two of the first companies commercializing psychedelic medicine. Christian also launched a fund dedicated to mental and neurological health called re:Mind, is an investor through his family office Apeiron, and co-founded two longevity biotech companies.

Credits:

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank

Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love

Additional Music:
Distant Daze by Zack Frank